SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is experiencing a significant surge as investors cheer reports that the U.S. government has approved the sale of advanced H200 AI chips to major Chinese tech firms, effectively reopening a key revenue channel. The community is actively debating the stock's massive market valuation and geopolitical implications, with many traders leaning into a bullish momentum play leading up to next week's earnings.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market sentiment surrounding the QQQ is defined by a tug-of-war between persistent bullish momentum driven by AI sector performance and cautious participants bracing for a potential volatility spike ahead of monthly options expiration. Traders are actively debating whether current dips represent tactical buying opportunities or the onset of a broader correction, with many fixated on the influence of institutional capital flows and bond yield sensitivity.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as investors react to a significant earnings beat and raised full-year revenue guidance, sparking intense debate over whether the stock's growth potential justifies its complex capital structure. The community is actively weighing the company's surging backlog and defense partnerships against persistent concerns regarding dilution and the influence of market makers on share price volatility.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently trending as investors weigh the potential impact of Elon Musks participation in a high-level U.S.-China summit alongside the anticipation surrounding a possible SpaceX IPO. Market sentiment remains divided, with community discussions heavily focused on technical options activity, the stock's recent volatility near the $450 level, and conflicting outlooks on how China-related business developments will influence future fundamentals.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is facing intense volatility as investors debate whether recent pullbacks represent a healthy correction or the start of a structural reversal amid broader concerns over semiconductor valuations. The community remains deeply divided, with bulls actively buying the dip to maintain exposure to the AI super-cycle while bears point to excessive technical overextension and potential downside risk.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is rallying as a massive earnings beat and upward revenue guidance reinforce its status as a core infrastructure player in the AI semiconductor supercycle. The community is actively debating the company's long-term growth potential and durability of AI-driven capital expenditure, while traders closely monitor its role in enabling leading-edge logic, memory, and advanced packaging technologies.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station (GEMI) is trending after securing a $100 million strategic investment from the Winklevoss Capital Fund, a move investors view as a major bullish signal that bolsters the balance sheet. Community discussion is intensely focused on the potential for a significant short squeeze, given the high short interest and the sentiment that the firm is now better positioned for long-term growth following stronger-than-expected quarterly results.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as investors aggressively debate the sustainability of the semiconductor sector's parabolic rally, which has been fueled by AI infrastructure spending and ongoing geopolitical developments surrounding the US-China summit. Community sentiment is deeply polarized, with bears anticipating a major correction due to concerns over high valuations, inflation, and excessive retail exposure, while bulls continue to bet on sustained momentum and massive capex cycles.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is facing significant downward pressure and volatility following a clinical hold on its pipeline that has sparked widespread regulatory uncertainty among investors. Despite strong long-term data for RGX-202 and the strategic AbbVie partnership, the community is actively debating the likelihood of approval versus a potential rejection.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending as traders closely monitor a potential supply-chain vacuum caused by a brewing strike at Samsung, leading to community speculation that Micron could capture increased market share and pricing power from major tech firms. Discussions are heavily focused on the stock's volatility driven by options expiry and the community's debate over whether AI demand justifies the stock's rapid valuation re-rating.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Royal Bank Of Canada Issues Positive Forecast for Pacira BioSciences (NASDAQ:PCRX) Stock Price

Royal Bank Of Canada raised their price target on shares of Pacira BioSciences from $22.00 to $24.00 and gave the company a "sector perform" rating in a research report on Friday...

Pacira Q1 Earnings Miss Estimates on Higher Costs, Revenues Rise Y/Y

PCRX Q1 earnings miss estimates as rising costs weigh on profit, but revenues top expectations on Exparel demand and growth from Zilretta and iovera.

Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up Following Analyst Upgrade

Pacira BioSciences (NASDAQ:PCRX) Shares Gap Up After Analyst Upgrade...

Pacira BioSciences' CFO Sold 12,941 Shares for $326,000 Before Its Q1 Earnings Release

Key PointsCFO Shawn Cross exercised and sold 12,941 shares on April 23, 2026, for a transaction value of ~$326,000 at around $25.16 per share...

Needham & Company LLC Raises Pacira BioSciences (NASDAQ:PCRX) Price Target to $32.00

Needham & Company LLC boosted their target price on Pacira BioSciences from $30.00 to $32.00 and gave the stock a "buy" rating in a report on Friday...

Pacira BioSciences (NASDAQ:PCRX) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Pacira BioSciences (NASDAQ:PCRX - Get Free Report) issued its quarterly earnings results on Thursday. The company reported $0.60 EPS for the quarter, missing the consensus estimate of $0.61 by...

Pacira BioSciences Q1 Earnings Call Highlights

Pacira BioSciences (NASDAQ:PCRX) reported first-quarter 2026 results that management said reflect continued momentum under its 5x30 strategy, highlighted by year-over-year growth across its three...

Pacira (PCRX) Q1 Earnings Miss Estimates

Pacira (PCRX) delivered earnings and revenue surprises of -1.64% and +0.58%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Pacira BioSciences Q1 2026 Earnings Call Transcript

Do Options Traders Know Something About Pacira BioSciences Stock We Don't?

Investors need to pay close attention to PCRX stock based on the movements in the options market lately.

Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients’ journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.

PCRX
Pacira BioSciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PCRX News

PCRXPacira BioSciences Inc